Takashi Eto

599 total citations
37 papers, 443 citations indexed

About

Takashi Eto is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Takashi Eto has authored 37 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 6 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Takashi Eto's work include Medical Imaging and Pathology Studies (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Diabetes Treatment and Management (4 papers). Takashi Eto is often cited by papers focused on Medical Imaging and Pathology Studies (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Diabetes Treatment and Management (4 papers). Takashi Eto collaborates with scholars based in Japan, United States and Germany. Takashi Eto's co-authors include Masanari Shiramoto, S. Irie, Harumi Suzuki, Y. Nagashima, Toshinari Takamura, Akio Fujimura, Shuichi Kaneko, Hitoshi Ando, Hirofumi Misu and Kosuke R. Shima and has published in prestigious journals such as Cancer, Journal of Bacteriology and Diabetologia.

In The Last Decade

Takashi Eto

33 papers receiving 436 citations

Peers

Takashi Eto
Isaac Rosado‐Sánchez Spain
Jessica L. Hill United States
Xiaohui Kong China
Solenne Taront France
Martin R. Späth Germany
Karolina M. Andralojc Netherlands
Syusaku SUZUKI Japan
Ting Lin China
Yaron Aviv Israel
In Sun Park South Korea
Isaac Rosado‐Sánchez Spain
Takashi Eto
Citations per year, relative to Takashi Eto Takashi Eto (= 1×) peers Isaac Rosado‐Sánchez

Countries citing papers authored by Takashi Eto

Since Specialization
Citations

This map shows the geographic impact of Takashi Eto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takashi Eto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takashi Eto more than expected).

Fields of papers citing papers by Takashi Eto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takashi Eto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takashi Eto. The network helps show where Takashi Eto may publish in the future.

Co-authorship network of co-authors of Takashi Eto

This figure shows the co-authorship network connecting the top 25 collaborators of Takashi Eto. A scholar is included among the top collaborators of Takashi Eto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takashi Eto. Takashi Eto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Eto, Takashi, et al.. (2025). Pharmacokinetics and safety of gadopiclenol in Japanese healthy volunteers. Japanese Journal of Radiology. 43(12). 1962–1970.
2.
Hasunuma, Tomoko, Clive Grattan, Takashi Eto, et al.. (2025). Pharmacokinetics and safety of CT‑P39 via auto-injector are comparable to reference omalizumab via pre-filled syringe. Immunotherapy. 17(2). 113–121.
3.
Haranaka, Miwa, Takashi Eto, Takanori Tanaka, et al.. (2024). Pharmacokinetics and Safety of Intravenous Candidate Biosimilar CT‐P47 and Reference Tocilizumab: A Randomized, Double‐Blind, Phase 1 Study. The Journal of Clinical Pharmacology. 65(2). 233–241. 2 indexed citations
4.
Eto, Takashi, Miwa Haranaka, Niels Rode Kristensen, et al.. (2024). Pharmacological characteristics of once‐weekly insulin icodec in Japanese individuals with type 1 diabetes. Journal of Diabetes Investigation. 16(3). 434–441. 2 indexed citations
5.
6.
Uchiyama, Makoto, Kazuo Mishima, Tomoko Yagi, et al.. (2024). Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies. Journal of Sleep Research. 34(1). e14302–e14302. 4 indexed citations
7.
Okada, Hiroshi, Kensuke Ishikawa, Y. Itoh, et al.. (2023). Safety, tolerability, and pharmacokinetics of half-life extended SARS-CoV-2–neutralizing monoclonal antibodies AZD7442 (tixagevimab/cilgavimab) in healthy Japanese adults. Journal of Infection and Chemotherapy. 29(11). 1061–1067. 6 indexed citations
8.
Toyama, Kaoru, et al.. (2023). Pharmacokinetics and Bioequivalence of Mirogabalin Orally Disintegrating Tablets and Conventional Tablets in Healthy Japanese Participants. Clinical Pharmacology in Drug Development. 12(10). 985–990. 1 indexed citations
9.
Toyama, Kaoru, Takashi Eto, Kenji Takazawa, et al.. (2023). DS-5670a, a novel mRNA-encapsulated lipid nanoparticle vaccine against severe acute respiratory syndrome coronavirus 2: Results from a phase 2 clinical study. Vaccine. 41(38). 5525–5534. 9 indexed citations
10.
Tamura, Hiroshi, Koji Fujii, Kiichiro Toyoizumi, et al.. (2023). Safety, reactogenicity, and immunogenicity of Ad26.COV2.S: Results of a phase 1, randomized, double-blind, placebo-controlled COVID-19 vaccine trial in Japan. Vaccine. 41(9). 1602–1610. 4 indexed citations
11.
Eto, Takashi, et al.. (2021). A randomized, single-dose, pharmacokinetic equivalence study comparing MB02 (proposed biosimilar) and reference bevacizumab in healthy Japanese male volunteers. Cancer Chemotherapy and Pharmacology. 88(4). 713–722. 7 indexed citations
12.
13.
Tsuji, Daiki, Takashi Daimon, Keisei Taku, et al.. (2013). Retrospective Analysis of Severe Neutropenia in Patients Receiving Concomitant Administration of Docetaxel and Clarithromycin. Chemotherapy. 59(6). 407–413. 7 indexed citations
14.
Ando, Hitoshi, Kentaro Ushijima, Masafumi Kumazaki, et al.. (2010). ASSOCIATIONS OF METABOLIC PARAMETERS AND ETHANOL CONSUMPTION WITH MESSENGER RNA EXPRESSION OF CLOCK GENES IN HEALTHY MEN. Chronobiology International. 27(1). 194–203. 24 indexed citations
15.
Tsukuda, Katsunori, M Kikuchi, S. Irie, et al.. (2009). Evaluation of the 24-Hour Profiles of Physiological Insulin, Glucose, and C-Peptide in Healthy Japanese Volunteers. Diabetes Technology & Therapeutics. 11(8). 499–508. 5 indexed citations
16.
Ando, Hitoshi, Toshinari Takamura, Naoto Nagata, et al.. (2008). Clock gene expression in peripheral leucocytes of patients with type 2 diabetes. Diabetologia. 52(2). 329–335. 108 indexed citations
17.
Eto, Takashi, et al.. (1999). Specific Tumor Development of Goblet Cell Type Mucus-Producing Adenocarcinomas of Lung.. Haigan. 39(6). 813–820. 1 indexed citations
18.
Yokota, Naoko, Yutaka Yamamoto, K Kitamura, et al.. (1991). Renal tubular lesions induced by human Bence Jones protein in the rat: N-acetyl-beta-D-glucosaminidase as a sensitive marker.. PubMed. 72(3). 255–62. 3 indexed citations
19.
Eto, Takashi, et al.. (1990). Alveolar elastosis in peripheral pulmonary adenocarcinoma in relation to tumor development.. Haigan. 30(4). 505–512. 4 indexed citations
20.
鈴木, 大拙, et al.. (1961). Sengai : 1750-1837.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Isaac Rosado‐Sánchez Breakdown of academic impact, for papers by Jessica L. Hill Breakdown of academic impact, for papers by Xiaohui Kong Breakdown of academic impact, for papers by Solenne Taront Breakdown of academic impact, for papers by Martin R. Späth Breakdown of academic impact, for papers by Karolina M. Andralojc Breakdown of academic impact, for papers by Syusaku SUZUKI Breakdown of academic impact, for papers by Ting Lin Breakdown of academic impact, for papers by Yaron Aviv Breakdown of academic impact, for papers by In Sun Park
Rankless by CCL
2026